|
1
|
|
|
2
|
|
|
3
|
|
|
4
|
- Epidemiology of meth and risk behaviors
- Interactions of meth and treatment medications
- Efficacious Interventions for meth-using MSM
- Case Studies
|
|
5
|
|
|
6
|
- More than 35 million use ATS worldwide, 2nd most popular drug
of abuse after cannabis (U.N., 2004)
- Meth treatment admissions in 2002 outpaced cocaine and heroin in 14 U.S.
states in the West, Midwest and South (OAS, 2005)
- Over 50% of Prop 36 admissions are for methamphetamine (Longshore et
al., 2005)
|
|
7
|
|
|
8
|
- Females (higher rates of depression; very high rates of previous and
present sexual and physical abuse; responsibilities for children).
- MA users who take MA daily or in very high doses.
- Homeless, chronically mentally ill and/or individuals with high levels
of psychiatric symptoms at admission.
- Individuals under the age of 21.
- Gay/bisexual men and other MSM
(at very high risk for HIV transmission).
- Rural
|
|
9
|
|
|
10
|
- Prevalence:
- Los Angeles (11%) of adult MSM used meth in past 6 months (Stall et al.,
2001)
- MSM aged 15-22 (20.1%) used meth in past 6 months (Thiede et al., 2003)
- Twice as many MSM (14.4%) used meth in 1996 NHSDA as MSW (7.3%; Cochran
et al., 2004)
|
|
11
|
|
|
12
|
- Local declines:
- Monitoring the Future declines
- Meth crimes in Montana
- Employee urine tests in Montana
- ED admits in San Francisco
- Mom & Pop labs in US
- But:
- Increases in meth deaths in South FL (77 in 2003 to 115 in 2006)
- 25% of gay men tested for HIV at LAGLC reported using meth in past year
at least once (Rudy et al., 2007)
|
|
13
|
- Issues of identity (gay, drug user, HIV status)1
- Enhance sexual functioning 2
- Boosts self confidence 2
- Increases productivity 2
- Weight loss/strong body experiences 2
- Brightens mood 2
- Aging/living with AIDS 3
|
|
14
|
|
|
15
|
|
|
16
|
- Participants expressed the importance of sex in their lives
- Participants discussed the relationship between their gay
identity and gay sex
- For many, methamphetamine use is a positive coping mechanism
- For others, their methamphetamine use is consistent with positive gay
sex and sexuality
|
|
17
|
|
|
18
|
- All participants discussed the
enhancement of their sexual activities while on methamphetamine:
è Heightened sensory experiences
è Disinhibiting effects
è Duration of sexual arousal
è Intensified orgasms
“I’m not sexually excited unless I’m under the influence. . .
. I don’t have sex without
crystal.” 29 years old,
white, HIV+
|
|
19
|
|
|
20
|
|
|
21
|
|
|
22
|
- The impact of HIV continues to be a salient factor directly influencing
the sexual lives of gay men
- At this historical moment gay identity is still linked to HIV and one’s
sexual expression becomes infused with death
- Participants report using methamphetamine to:
_ dissociate from fears
associated with sex
_ cope with grief and
loss
_ alleviate physical and
psychological HIV-related pain
|
|
23
|
|
|
24
|
- Many of the effects associated with methamphetamine use complement
valued aspects of gay culture
- Methamphetamine use is facilitated through various gay institutions such
as chat rooms, personal ads, circuit parties, bars and clubs
- All participants used methamphetamine during their sexual activities.
- All participants discussed the enhancement of their sexual experiences
while on methamphetamine.
- Sex was seen as more intense, heightened, prolonged and uninhibited.
- Several HIV-infected participants discussed the advantages of using
methamphetamine to manage AIDS-related conditions or effects.
|
|
25
|
|
|
26
|
- In Los Angeles County, heroin injectors at low risk; gay male meth users
at extreme risk
|
|
27
|
|
|
28
|
|
|
29
|
|
|
30
|
- Many participants (3492) report being under influence while having sex,
past 6 months (Celentano et al., 2006)
|
|
31
|
|
|
32
|
- Project INSPIRE: HIV+ meth users engage in sex risks, but IDU not
predictive of unprotected anal sex with negatives (Purcell et al., 2006)
- HIV+ IDUs have significantly more healthcare and economic disparities,
lower employment, income, less gay identified, likely AIDS dx, sexual
abused (Ibanez et al 2005; Semple et al., 2004)
|
|
33
|
- MSM HIV incidence = 1.6 per 100 ppy (95% CI=1.23-1.95; Buchbinder et
al., 2005)
- Corresponds to 19.1% prevalence (95% CI=12.8% to 25.3%)
- Detuned assays of 290 MSM meth users in SF at anonymous testing sites:
Incidence estimated 6.3% (95% CI=1.9-10.6) compared to 2.1% (95%
CI=1.3-2.9) for 2701 non-drug using MSM (Buchacz et al., 2005)
- MACS: HIV seroconversion
increased ~3 times for MSM who use meth and poppers (Plankey et al.,
2007)
|
|
34
|
- Los Angeles* United States**
- MSM 76% 59%
- MSM and IDU 7% 9%
- IDU 5% 22%
- Other 12% 10%
- *July 2006 HIV Epidemiology Report, LA County
- **2005 HIV/AIDS Surveillance Report, CDC
|
|
35
|
- A Probabilistic Event Determined by:
- Characteristics of the behavior
- Unprotected anal (
receptive; ¯
insertive)
- Unprotected vaginal (
receptive; ¯
insertive)
- Oral behaviors
- Characteristics of the individual
- Other STIs
- Bruised/bleeding mucosa
- Viral load
- Concurrency
- Characteristics of the event
- Single; multiple sources of virus
|
|
36
|
|
|
37
|
- Rapid heart rate, high blood pressure, rapid breathing, high body
temperature, agitation
- Kidney disease and strokes
- Heart attacks, especially in young patients (29-45)
- Meth smoking associated with acute pulmonary hypertension: inability to
catch one’s breath
- Impairs CD8 T-lymphocyte function
|
|
38
|
- Psychosis, depression, violence, family and social disruptions, criminal
activity[1]
- Among MSM, abuse increases likelihood of infection with HIV[2]
- May exacerbate neurotoxicity and other pathological processes common to
HIV infection (Markowitz et al., 2005)
- May worsen the HIV epidemic and complicate treatment of HIV[3]
|
|
39
|
- Protease inhibitors commonly metabolized by liver enzyme, CYP3A4
- Ritonavir also induces CYP2D6 enzymes
- 3- to 10-time increase in levels of MA or MDMA in patients taking
ritonavir[1]
- Deaths reported for HIV patients using MA and MDMA; all reports
indicate ritonavir-containing regimens
- SAFETY POINT: Urge patients to talk with HIV docs about their meth use
|
|
40
|
- Use of drugs, especially stimulant drugs, reduces HAART adherence
- 3-day reported adherence rates:
- On stimulants: 51%
- Off stimulants: 72%
- Main effects of meth observed on behavioral organization
|
|
41
|
|
|
42
|
- Pharmacological Targets
- Substitution (agonists, e.g., modafinil)
- Relieve withdrawal symptoms (e.g., bupropion)
- Behavior Therapy Targets
- Instilling of abstinence
- Prevention of relapse
- Improve mood and cognition
- Reduce craving
- None of these targets imply cure
|
|
43
|
- What level of treatment do you recommend?
- ANS: Start where the patient is
at
- Least intensive form of treatments precede more intensive treatments
- When do you recommend treatment?
- ANS: Within moments of the request
- How do you know when is enough treatment?
- What do you recommend for lapse? Relapse? Worsening use? Continued use?
- More of the same? Or something different?
|
|
44
|
- Disorder of impulse control
- Cognitive and behavioral “brakes” are shot
- Key factor is ambivalence
- The unresolved tension: is it a problem or is it no problem?
- Lots of omorbidities…but which do you treat, and when?
- How do you know when your patient is lying?
- Essential to use biomarkers – get a urine sample!
|
|
45
|
- Drugs always have functional aspects that facilitate their use
- These functional aspects are important to treatment process:
- Increased productivity
- Weight loss
- Enhance sexual functioning
- Organizes aspects of culture
|
|
46
|
- Buproprion showing some efficacy for light users (Elkashef et al., 2007)
- Some initial evidence for methylphenidate (Tiihonen et al., 2007)
- Use of modafinil as a treatment for fatigue with HIV-positive patients
in treatment (Rabkin et al., 2004)
|
|
47
|
- Simple
- Repeated
- Short
- On message
- Pictures
|
|
48
|
|
|
49
|
|
|
50
|
|
|
51
|
|
|
52
|
- Despite elegant constructions of drug use in depth psychotherapy,
outcome studies do not support this technique
- Good rule of thumb is to begin psychotherapy within 3-6 months after
drug discontinuation
|
|
53
|
|
|
54
|
- HIV risk taking
- HIV acquisition
- Non-adherence to HIV medications
|
|
55
|
|
|
56
|
|
|
57
|
- Behavioral Prevention
- Biological Adjuncts
|
|
58
|
|
|
59
|
|
|
60
|
- Street Outreach
- Skills Building Groups
- Support Groups
- Health Education / Risk Reduction
|
|
61
|
- Sites: bars, cruising areas,
parks, coffee houses, street corners, inexpensive hotels, bus stops,
abandoned buildings, parking lots, fast food stands, mini markets
|
|
62
|
- Harm reduction
- Empower not enable
- Working with clients on their own agenda
- Being client-centered
- Being value clear
- Suspended judgment
|
|
63
|
- Park / Cruising Area
- _ No membership fee
- _ No entrance fee
- _ No condoms are provided
- _ Very unsafe environment for anonymous sex
- _ Atmosphere of excitement and danger, risk police entrapment and gay
bashing
- _ Average stay, 30 minutes - 1 hour
|
|
64
|
- Bathhouse
- _ Membership fee, $25/3 months
- _ Entrance fee, $8-30/8 hours
- _ Condoms are provided
- _ Very safe environment for anonymous sex
- _ Party atmosphere (restaurant, gymnasium)
- _ Average stay, 6-8 hours
|
|
65
|
- Armando: Hi, beautiful.
- Fernando: Hi. How are you?
- Armando: I’m fine thank you. What are you doing?
- Fernando: Just sitting here. Talking to folks.
- Armando: Talking about what?
- Fernando: I am here to answer any questions you might have about drugs,
sex and HIV.
- Armando: Sex, drugs and HIV?
- Fernando: Yes. Do you have any questions?
- Armando: You are so beautiful.
- Fernando: Thank you, but do you have any questions?
- Armando: No. But if I do, I will come back and talk to you.
|
|
66
|
- Armando: Hi, beautiful.
- Fernando: Hi. How are you?
- Armando: Can I ask you something?
- Fernando: Yes, sure.
- Armando: I want to know if you can get infected if you have oral sex?
|
|
67
|
- Curriculum-based groups dealing with HIV prevention issues in relation
to methamphetamine use:
- The ABCs of Hepatitis
- Dealing with Emotions
- STDs
- Self-esteem
- Sexuality and Homophobia
- Staying Safe
- Street Drugs and HIV Medications
|
|
68
|
- VIPS (behavioral intervention) layered on top of The G.U.Y.S. Program
(HE/RR intervention)
- Voucher-based incentive therapy (Contingency Management)
- Earn vouchers for completing prosocial and healthy behaviors and/or
submitting drug-negative urine and alcohol-negative breath samples
- Redeem vouchers for goods or services
|
|
69
|
|
|
70
|
|
|
71
|
|
|
72
|
|
|
73
|
|
|
74
|
- Motivational Interviewing
- Harm Reduction Group Counseling
- Drop-in Groups
- Information Technology (IT)
|
|
75
|
|
|
76
|
|
|
77
|
|
|
78
|
|
|
79
|
|
|
80
|
- Cognitive Behavioral Therapy
- Contingency Management
- Combined CBT + CM
|
|
81
|
|
|
82
|
|
|
83
|
|
|
84
|
|
|
85
|
- Variable N %
- Unprotected insertive anal intercourse
60 37%
- ? Of those, 83% were
using methamphetamine
- Unprotected receptive anal intercourse 61 38%
- ? Of those, 84% were
using methamphetamine
|
|
86
|
- For some participants, non-adherence related to methamphetamine use was
conscious and planned:
- _ Partying/escape/medication vacations
- _ Avoiding drug mixing and toxicity
- For other participants, non-adherence related to methamphetamine use was
unconscious and unplanned:
- _ Inability to maintain a schedule
- _ Sleeping through doses
- _ Inability to eat or drink
|
|
87
|
- Gerry: “When high, I didn’t take
my meds, I didn’t think to. The adventure would just start and I would
go with it and I wasn’t planning.
I didn’t plan and I wasn’t prepared. That was part of the fun of the
adventure, that it was so spontaneous and impulsive.”
- Wayne: “I don't do any [meds] while using.
When I do use [meth] I'd literally lie on a bed in a hotel, bathhouse,
or my house, and I barely drink any liquids or eat. And that might be twenty-four
hours. I have total focus on just
having sex. Nothing else
matters… [The meds] don't enter
my mind… I don’t even
shower. I couldn’t care less. If
there was a way that I could pee without getting up from sitting there
and masturbating, I would have invented it.”
|
|
88
|
- Rich: “If I’m not on drugs, it’s
pretty much habitual. I wake up
and take my medicine or go to bed.
I don’t even think about it. When I’m using crystal there is no
going to bed and usually I take my medicine when I wake up and when I go
to bed. I know that I should take
it at a certain time because that’s when I normally would wake up but
[on meth] I might just let that time go and go and go.”
- Matthew: “I’d miss so many doses
and then try to take it. You
don’t keep track of time, you don't keep track of food schedules and
stuff. With crystal, the schedule
was blown out of the water.”
|
|
89
|
|
|
90
|
|
|
91
|
|
|
92
|
- Significantly longer retention
- Significantly more “clean urine”
- Significantly longer stretches of consecutive clean urine samples
|
|
93
|
|
|
94
|
|
|
95
|
|
|
96
|
|
|
97
|
|
|
98
|
|
|
99
|
|
|
100
|
|
|
101
|
|
|
102
|
|
|
103
|
|
|
104
|
|
|
105
|
|
|
106
|
|
|
107
|
|
|
108
|
|
|
109
|
|
|
110
|
|
|
111
|
|
|
112
|
|
|
113
|
- Policy recommendation for gay/bisexual and other MSM methamphetamine
users:
- _ Treatment Works!
- _ Drug abuse treatment is HIV prevention
- _ Concomitant focus on sexual and drug behaviors reduces HIV risk
behaviors
|
|
114
|
|